HOUSE OF REPRESENTATIVES
THE THIRTIETH LEGISLATURE
REGULAR SESSION OF 2020
Rep. John M. Mizuno, Chair |
Rep. Bertrand Kobayashi, Vice Chair |
Rep. Della Au Belatti |
Rep. Calvin K.Y. Say |
Rep. Nadine K. Nakamura |
Rep. James Kunane Tokioka |
Rep. Joy A. San Buenaventura |
Rep. Gene Ward |
NOTICE OF HEARING
DATE: |
Thursday, March 12, 2020 |
TIME: |
9:00 a.m. |
PLACE: |
Capitol Auditorium State Capitol 415 South Beretania Street |
A G E N D A
RELATING TO HEALTH. Amends the definition of "preceptor" and "volunteer-based supervised clinical training rotation" to improve accessibility for providers to receive income tax credits for acting as preceptors. Revises the membership of the Preceptor Credit Assurance Committee to include the Director of Health. Effective 7/1/2050. (SD3)
|
HLT, CPC, FIN |
|
RELATING TO BEHAVIOR ANALYSTS. Makes permanent the regulation of behavior analysts. Exempts behavior analysts licensing program from auditor evaluation requirement. (SD1)
|
HLT, CPC, FIN |
|
RELATING TO HEALTH INSURANCE. Prohibits nonparticipating health care providers from balance billing patients in specific circumstances. Establishes rate calculation requirements for reimbursement of nonparticipating providers. Repeals January 2, 2025. Effective 1/2/2050. (SD2)
|
HLT, CPC, FIN |
|
RELATING TO MEDICAL SERVICE BILLING. Establishes billing requirements for unanticipated medical billing and unanticipated coverage gaps of patients for out-of-network emergency services received from non-participating providers. Requires the Insurance Commissioner to refer certain disputes between insurers and non-participating providers to an independent dispute resolution entity for binding arbitration. Effective 1/1/2021. (SD1)
|
HLT, CPC, FIN |
|
RELATING TO HEALTH. Extends the state-funded medical assistance provided to pregnant women for up to 1 year post-pregnancy in certain circumstances. Effective 7/1/2050. (SD2)
|
HLT, CPC, FIN |
|
RELATING TO HEALTH INSURANCE. Requires insurers, mutual benefit societies, and health maintenance organizations to provide coverage for the cost of auto-injectable epinephrine based on appropriate weight-based dosage for insured persons eighteen years of age or younger, beginning 1/1/2021. (SD1)
|
HLT, CPC, FIN |
|
RELATING TO MEDICAL CANNABIS. Permits qualifying patients to be reimbursed by health insurers, mutual benefit societies, and health maintenance organizations for amounts spent on medical cannabis and manufactured cannabis products. Limits the monthly amount of reimbursement. Effective 7/1/2050. (SD1)
|
HLT, CPC/JUD, FIN |
|
RELATING TO MEDICAL CANNABIS. Authorizes the department of health to issue permits to medical cannabis dispensaries for the delivery of medical cannabis and manufactured cannabis products to qualifying patients or primary caregivers if certain conditions are met. Authorizes the department of health to issue medical cannabis transporter licenses in specific situations. (SD1)
|
HLT, CPC/JUD, FIN |
|
RELATING TO CHILDREN'S HEALTH. Requires the Department of Health to establish, implement, and evaluate a statewide program for early identification of, and intervention for, lead poisoning in infants. Requires insurers to provide coverage for the testing. Effective 7/1/2050. (SD2)
|
HLT, CPC, FIN |
|
RELATING TO LEAD-BASED PAINT. Prohibits the use of lead-based paint on outdoor structures after 12/31/21.
|
HLT, CPC, JUD |
|
RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM. Updates section 329-104(c), Hawaii Revised Statutes, to clarify who may access information stored in the electronic prescription accountability system. (SD1)
|
HLT, CPC/JUD, FIN |
|
RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM. Requires that the dispensing of a pharmacist-prescribed opioid antagonist be reported to the State's electronic prescription accountability system. (SD1)
|
HLT, CPC/JUD, FIN |
|
RELATING TO EMERGENCY MEDICAL SERVICES. Enables the Hawaii medical board to certify emergency medical responders other than emergency ambulance personnel. Effective 7/1/2050. (SD1)
|
HLT, CPC, FIN |
|
RELATING TO HEALTH CARE INSURANCE. Prohibits a health care insurer, mutual benefit society, or health maintenance organization from requiring an insured, subscriber, member, or enrollee diagnosed with stage two through stage four cancer to undergo step therapy prior to covering the insured for the drug prescribed by the insured's health care provider, under certain conditions, for health insurance policies and contracts issued or renewed after 12/31/2020. (SD1)
|
HLT, CPC, FIN |
DECISION MAKING TO FOLLOW
Persons wishing to offer comments should submit testimony at least 24 hours prior to the hearing. Testimony should indicate:
· Testifier's name with position/title and organization;
· The Committee(s) to which the comments are directed;
· The date and time of the hearing; and
· Measure number.
While every effort will be made to incorporate all testimony received, materials received on the day of the hearing or improperly identified or directed, may be distributed to the Committee after the hearing.
Submit testimony in ONE of the following ways:
PAPER: 10 copies (including an original) to Room 403 in the State Capitol;
FAX: For testimony less than 5 pages in length, transmit to 808-586-6311 (Oahu) or 1-800-535-3859 (for Neighbor Islander without a computer to submit testimony through e-mail or the Web); or
WEB: For testimony less than 20MB in size, transmit from http://www.capitol.hawaii.gov/submittestimony.aspx.
Testimony submitted will be placed on the legislative website. This public posting of testimony on the website should be considered when including personal information in your testimony.
If you require special assistance or auxiliary aids and/or services to participate in the House public hearing process (i.e., sign or foreign language interpreter or wheelchair accessibility), please contact the Committee Clerk at 586-6050 or email your request for an interpreter to HouseInterpreter@Capitol.hawaii.gov at least 24 hours prior to the hearing for arrangements. Prompt requests submitted help to ensure the availability of qualified individuals and appropriate accommodations.
|
|
________________________________________ Rep. John M. Mizuno Chair |
|
|
|